Search hospitals > Arizona > Scottsdale
HonorHealth Research Institute
Claim this profileScottsdale, Arizona 85258
Global Leader in Solid Tumors
Global Leader in Tumors
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Melanoma
152 reported clinical trials
14 medical researchers
Summary
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Tumors, Pancreatic Cancer, Cancer, Melanoma and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 190 conditions. There are 14 research doctors associated with this hospital, such as Michael S Gordon, MD, Vincent Chung, MD, Erkut Borazanci, MD, and Sunil Sharma.Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
metastatic
2Tumors
Global LeaderStage IV
Stage III
metastatic
Top PIs
Michael S Gordon, MDHonor Health Research Institute1 year of reported clinical research
Studies Tumors
Studies Solid Tumors
17 reported clinical trials
25 drugs studied
Vincent Chung, MDCity of Hope Medical Center1 year of reported clinical research
Expert in Adenocarcinoma
Expert in Pancreatic Cancer
19 reported clinical trials
31 drugs studied
Erkut Borazanci, MDHonorHealth1 year of reported clinical research
Studies Pancreatic Cancer
Studies Solid Tumors
13 reported clinical trials
22 drugs studied
Sunil SharmaHonorHealth Research Institute3 years of reported clinical research
Studies Tumors
Studies Solid Tumors
15 reported clinical trials
31 drugs studied
Clinical Trials running at HonorHealth Research Institute
Solid Tumors
Tumors
Melanoma
Non-Small Cell Lung Cancer
Cancer
Colorectal Cancer
Ovarian Cancer
Stomach Cancer
Breast Cancer
Endometrial Cancer
Dabrafenib + Trametinib Access
for Cancer
This study is evaluating whether a combination of drugs may help patients with a certain type of cancer.
Recruiting3 awards Phase 42 criteria
INBRX-109
for Solid Tumors
This study is evaluating whether a new drug may help treat cancer.
Recruiting1 award Phase 1
GIM-531
for Solid Tumors
GIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy. GIM-531 exhibits its primary effect through selective inhibition of regulatory T-cells (Tregs).
Recruiting1 award Phase 1 & 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at HonorHealth Research Institute?
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Tumors, Pancreatic Cancer, Cancer, Melanoma and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 190 conditions. There are 14 research doctors associated with this hospital, such as Michael S Gordon, MD, Vincent Chung, MD, Erkut Borazanci, MD, and Sunil Sharma.